期刊文献+

高表达重组Ret蛋白B16细胞株的建立

ESTABLISHMENT OF B16 CELL LINE WITH HIGH EXPRESSION OF RECOMBINANT RET PROTEIN
下载PDF
导出
摘要 目的:探讨建立高表达重组Ret蛋白的B16细胞株的方法,为Ret抗原的免疫原性研究提供靶细胞。方法:通过常规分子克隆的方法,构建Fxyd3-Ret嵌合蛋白的真核表达质粒pIRES-rFxyd3-His-Ret-neo2;将该质粒转染293细胞以验证构建质粒的可行性;将该质粒转染B16细胞,通过筛选获得Fxyd3-Ret蛋白高表达的阳性细胞株。结果:PCR和酶切验证pIRES-rFxyd3-His-Ret-neo2的产物片段大小符合预期,Western blot对转染pIRES-rFxyd3-His-Ret-neo2质粒的细胞进行检测,发现在转染细胞内有目标蛋白高表达。结论:成功构建了pIRES-rFxyd3-His-Ret-neo2真核转染质粒;成功建立了Ret蛋白高表达的B16细胞株。 Objective:To explore the establishment of B16 cell line with high expression of recombinant Ret protein to provide the target cell for the immunogenicity research of Ret antigen.Methods:The euokryotic expression vector pIRES-rFxyd3-His-Ret-neo2 was constructed and the Ret expression of the vector in 293 cell was verified.The pIRES-rFxyd3-His-Ret-neo2 vector was transfected to B16 cell and the clones with high expresion of recombinant Ret protein was selected.Results:The sequence of pIRES-rFxyd3-His-Ret-neo2 was confirmed according to the PCR and restriction enzymic analysis.The transfected cells were proved expressing Ret protein.Conclusion:The results indicate that the eucaryotic expressing vector pIRES-rFxyd3-His-Ret-neo2 was constructed and the B16 cell line with high expression of recombinant Ret was established.
出处 《广西医科大学学报》 CAS 2010年第4期504-506,共3页 Journal of Guangxi Medical University
基金 广东省自然科学基金资助项目(No.9451018201003599)
关键词 重组Ret蛋白 B16细胞株 Fxyd3 recombinant Ret protein B16 cell line Fxyd3
  • 相关文献

参考文献9

  • 1Plaza-Menacho I,Burzynski GM,De Groot JW,et al.Current concepts in RET-related genetics,signaling and therapeutics[J].Trends Genet,2006,22:627-636.
  • 2Mulligan LM,Kwok JB,Healey CS,et al.Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A[J].Nature,1993,363:458-460.
  • 3Carlson KM,Dou S,Chi D,et al.Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B[J].Proc Natl Acad Sci USA,1994,91:1 579-1 583.
  • 4Donis-Keller H,Dou S,Chi D,et al.Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC[J].Hum Mol Genet,1993,2:851-856.
  • 5Hoff AO,Hoff PM.Medullary thyroid carcinoma[J].Hematol Oncol Clin North Am,2007,21:475-488.
  • 6Morrison BW,Leder P.Neu ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors[J].Oncogene,1994,9(12):3 417-3 426.
  • 7Kouvaraki MA,Shapiro SE,Perrier ND,et al.RET proto-oncogene:a review and update of genotype phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors[J].Thyroid,2005,15:531-544.
  • 8Kodama Y,Asai N,Kawai K,et al.The RET protooncogene:a molecular therapeutic target in thyroid cancer[J].Cancer Sci,2005,96:143-148.
  • 9Morrison BW,Moorman JR,Kowdley GC,et al.Mat-8,a Novel Phospholemman-like Protein Expressed in Human Breast Tumors,Induces a Chloride Conductance in Xenopus Oocytes[J].J Bio Chem,1995,270(5):2 176-2 182.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部